Skip to content
Novoic logo — Predicting brain disease from speech

Novoic

Predicting brain disease from speech

Founded 2019 United Kingdom London, United Kingdom 6 employees Seed Total: $2.00M AI, Biotechnology +3

General Information

Company Name Novoic
Founded Year 2019
Location United Kingdom London, United Kingdom
Employees 6
Industries AI, Biotechnology, Health Care +2
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Novoic. To contact Novoic, visit novoic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novoic compare?

A PDF of Novoic and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novoic soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novoic

Novoic is a UK-based startup with the slogan "Predicting brain disease from speech." Founded in 2019, the company focuses on utilizing AI, Biotechnology, Health Care, Medical Devices, and Machine Learning to radically early detect brain diseases by analyzing the way individuals speak. In its latest round of funding in July 2020, Novoic secured a noteworthy £2.00M investment from a consortium of investors including Entrepreneur First, Apex Ventures, Stanford Angels and Entrepreneurs, Plug and Play, and Anthemis Exponential Ventures.

Business keywords: Digital Biotech, NLP, ML, Speech processing, Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Neurodegenerative dementias, Motor diseases, Speech disorders, Rare neurological diseases, Digital health, Early detection

Services & Products

AI-enabled speech-based cognitive assessment and early detection software for Alzheimer's disease

Target Customers

Medical centers healthcare institutions research organizations

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round £2.00M 5
Entrepreneur First, Apex Ventures +3
31 Jul 2020
Seed Round Undisclosed 1
Anthemis Group
09 Mar 2020

Novoic Alternatives & Competitors

View All Alternatives
Novoic vs
Imeka
Imeka Canada

We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Im...

22 employees
AI, Biotechnology
Novoic vs

Pioneering therapies to combat neurodegenerative diseases with innovative protein disaggregation tec...

Venture round
Biotechnology, Health Care
Novoic vs

AI software optimzes neuroradiological diagnostic and enables early detection of Alzheimer's & Co.

25 employees
AI, Health Care

FAQ About Novoic

Predicting brain disease from speech
Novoic was founded in 2019.
Novoic is headquartered in London, United Kingdom.
Novoic operates in AI, Biotechnology, Health Care, Medical Devices and Machine Learning. Its work centres on Digital Biotech, NLP, ML and Speech processing. Its customers include Medical centers, healthcare institutions and research organizations.
Novoic has approximately 6 employees.
Novoic has completed 2 funding rounds, raising a total of $2.00M. The latest funding stage is Seed.
Novoic offers: AI-enabled speech-based cognitive assessment and early detection software for Alzheimer's disease.
Top alternatives and competitors to Novoic include Imeka, Proclara Biosciences, AIRAmed GmbH, Reyedar, Lys Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novoic and Imeka are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novoic, https://bouncewatch.com/company/novoic, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout